Posts By Alex
375Wire StoriesNRS CORPORATION: Establishment of a New Logistics Site in Arizona, U.S.A.
TOKYO–(BUSINESS WIRE)–NRS CORPORATION is pleased to announce the opening of a new comprehensive logistics site in the U.S. state of Arizona, which...
- 548Wire Stories
Hanshow, Microsoft, Intel, and E Ink Jointly Release Industry White Paper Exploring Green Digitalization in the Future of Retail
BEIJING–(BUSINESS WIRE)–#DigitalRetail–Hanshow, Microsoft, Intel, and E Ink have issued a joint white paper on Green Digitalization – a process whereby the simultaneous...
- 561Wire Stories
Bloom Energy and SK ecoplant Announce 500 MW Sales Agreement Strengthening Existing Partnership
SAN JOSE, Calif. & SEOUL, South Korea–(BUSINESS WIRE)–Bloom Energy (NYSE: BE) and SK ecoplant, an engineering and energy solutions provider and subsidiary...
- 499Wire Stories
Stronghold Enters Into $15 Million Private Placement
Provides Panther Creek Plant Update NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Strongholdâ€, or the...
- 505Wire Stories
OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company has received approval...
- 630Wire Stories
Japan Video Games Market Report 2023- In-Depth Analysis of Japan’s Robust Gaming Market Unveiled – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Japan Games Market Report” report from Niko Partners, Inc. has been added to ResearchAndMarkets.com’s offering. As the world’s third largest...
- 423Wire Stories
2024 to Bring “Reputational Security†into Focus – Crisis Management Centre
KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–#CrisisCommunication–The Crisis Management Centre foresees that 2024 will carry with it increased threats to individuals, organisations and governments in...
- 486Wire Stories
FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial of BRUKINSA versus IMBRUVICA® (ibrutinib) in Relapsed...
- 404Wire Stories
VOOPOO DRAG X2 and DRAG S2 with PnP X Platform have Arrived in the MENA
SHENZHEN, China–(BUSINESS WIRE)–VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2, DRAG S2 with PnP X platform in the...
- 409Wire Stories
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
TOKYO–(BUSINESS WIRE)–Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusionâ€), a deep tech start-up developing a novel cell therapy, announced that the U.S....
